Myeloid and plasmacytoid dendritic cell vaccinations for castration-resistant prostate cancer patients.

被引：2
|
作者：
Westdorp, Harm
van Oort, Inge M.
Creemers, Jeroen H. A.
Schreibelt, Gerty
Mehra, Niven
de Goede, Anna L.
Hulsbergen-Van De Kaa, Christina
Figdor, Carl G.
Witjes, Alfred
Aarntzen, Erik H. J. G.
Mus, Roel D. M.
Gotthardt, Martin
Barentsz, Jelle O.
De Vries, Jolanda
Gerritsen, Winald R.
机构：
[1] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands
[2] Radboud Inst Mol Life Sci, Nijmegen, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 06期
关键词：
D O I：
10.1200/JCO.2018.36.6_suppl.219
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
219
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Castration-Resistant Prostate Cancer: AUA Guideline
    Cookson, Michael S.
    Roth, Bruce J.
    Dahm, Philipp
    Engstrom, Christine
    Freedland, Stephen J.
    Hussain, Maha
    Lin, Daniel W.
    Lowrance, William T.
    Murad, Mohammad Hassan
    Oh, William K.
    Penson, David F.
    Kibel, Adam S.
    JOURNAL OF UROLOGY, 2013, 190 (02): : 429 - 438
  • [42] Enzalutamide in Castration-Resistant Prostate Cancer Reply
    Hussain, Maha
    Saad, Fred
    Sternberg, Cora N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (14): : 1381 - 1381
  • [43] High Health-Related Quality of Life During Dendritic Cell Vaccination Therapy in Patients With Castration-Resistant Prostate Cancer
    Westdorp, Harm
    Creemers, Jeroen H. A.
    van Oort, Inge M.
    Mehra, Niven
    Hins-de Bree, Simone M.
    Figdor, Carl G.
    Witjes, J. Alfred
    Schreibelt, Gerty
    de Vries, I. Jolanda M.
    Gerritsen, Winald R.
    Ottevanger, Petronella B.
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [44] Experience of a Brazilian oncological center using abiraterone acetate in metastatic castration-resistant prostate cancer patients.
    Preto, Daniel D'Almeida
    Zucca, Luis Eduardo
    Carcano, Flavio Mavignier
    Zylberberg, Ricardo
    Neif, Joao Antonio Junior
    Fruet Filho, Carlos Alberto
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [45] Haptoglobin Proved a Prognostic Biomarker in Peripheral Blood of Patients with Personalized Peptide Vaccinations for Advanced Castration-Resistant Prostate Cancer
    Pang, Xiaoliang
    Tashiro, Kosuke
    Eguchi, Rieko
    Komatsu, Nobukazu
    Sasada, Tetsuro
    Itoh, Kyogo
    Kuhara, Satoru
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2013, 77 (04) : 766 - 770
  • [46] Efficacy of docetaxel in castration-resistant prostate cancer patients with intraductal carcinoma of the prostate
    Yamamoto, Akiyuki
    Kato, Masashi
    Matsui, Hirotaka
    Ishida, Ryo
    Kimura, Tohru
    Funahashi, Yasuhito
    Sassa, Naoto
    Matsukawa, Yoshihisa
    Kamihira, Osamu
    Hattori, Ryohei
    Gotoh, Momokazu
    Tsuzuki, Toyonori
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (03) : 584 - 590
  • [47] Efficacy of docetaxel in castration-resistant prostate cancer patients with intraductal carcinoma of the prostate
    Akiyuki Yamamoto
    Masashi Kato
    Hirotaka Matsui
    Ryo Ishida
    Tohru Kimura
    Yasuhito Funahashi
    Naoto Sassa
    Yoshihisa Matsukawa
    Osamu Kamihira
    Ryohei Hattori
    Momokazu Gotoh
    Toyonori Tsuzuki
    International Journal of Clinical Oncology, 2018, 23 : 584 - 590
  • [48] Olaparib for Metastatic Castration-Resistant Prostate Cancer
    de Bono, J.
    Mateo, J.
    Fizazi, K.
    Saad, F.
    Shore, N.
    Sandhu, S.
    Chi, K. N.
    Sartor, O.
    Agarwal, N.
    Olmos, D.
    Thiery-Vuillemin, A.
    Twardowski, P.
    Mehra, N.
    Goessl, C.
    Kang, J.
    Burgents, J.
    Wu, W.
    Kohlmann, A.
    Adelman, C. A.
    Hussain, M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (22): : 2091 - 2102
  • [49] Advances in metastatic castration-resistant prostate cancer
    Kentepozidis, Nikolaos
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S108 - S108
  • [50] Predicting the future in castration-resistant prostate cancer
    Verhagen, Paul
    LANCET ONCOLOGY, 2009, 10 (03): : 201 - 202
12345